Advances in Immunotherapy: Tackling CAR T-cell Therapy Resistance
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
Category: Research
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved the immunotherapeutic obinutuzumab (Gazyva) for...
The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently received funding from Genentech...
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most...
For AACR’s grants program, 2015 was indeed a successful year to reflect upon. Among many highlights, 2015 saw the...
This year has been a momentous year in healthcare, and, as some news outlets like Boston’s WBUR radio are...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when...
On Monday, the U.S. Food and Drug Administration (FDA) rounded out an exciting month for the multiple myeloma community...
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...
On Monday, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the immunotherapeutic...